Cellyan Biotechnology Co revenue was $20.31M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, HKPD annual revenue was $20.3M, with 21.7% growth year-over-year.
HKPD past revenue growth
How has HKPD's revenue growth performed historically?
Cellyan Biotechnology Co (NASDAQ: HKPD) reported Q1 2025 revenue of N/A up N/A year over year. In the same quarter last year, Cellyan Biotechnology Co's revenue was N/A.
What was Cellyan Biotechnology Co's revenue in 2025?
Cellyan Biotechnology Co's annual revenue for the twelve months ending Mar 31, 2025 was $20.31 million, a 21.72% increase year over year.
How much does Cellyan Biotechnology Co make in a day?
Based on Cellyan Biotechnology Co annual revenue for the past two years, HKPD makes an average of $50,687.92 per day.
What was Cellyan Biotechnology Co's annual revenue growth in the past year?
As of Q1 2026, Cellyan Biotechnology Co's revenue has grown 21.72% year over year. This is 10.16 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of 11.57%. Cellyan Biotechnology Co's revenue in the past year totaled $20.31 million.
How much does Cellyan Biotechnology Co make in a year?
Cellyan Biotechnology Co's revenue by year for the past two years is:
Cellyan Biotechnology Co's revenue for the twelve months ending Mar 31, 2025 was $20.31 million, a 21.72% increase year over year.
Cellyan Biotechnology Co's annual revenue for Mar 31, 2024 was $16.69 million, a 32.91% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.